[International approaches to the regulation of cell therapy products].

This article is a review of the main methods and approaches used in regulation of cell therapy products in the United States of America, Canada, European Union, Australia, Japan and South Korea. Intensive developments ofscientific and technological aspects in stem cell and tissue engineering have led to the wide use of human cells and tissues for the treatment of various diseases and injuries of organs and tissues. Drug regulatory agencies of different countries are working on implementation of a risk-based legal framework with some common features. In many countries there is a multilevel control system that assures quality and safety of used cell products. Competent authorities establish strict requirements both to safety of the products and to the implemented standards of good laboratory, manufacturing, clinical and tissue practices.

[Dental diseases prevention and treatment among foreign students from different regions of the world].

420 foreign first year students of Peoples' Friendship University of Russia from different regions of the world were examined for oral health status. The main dental indexes were analyzed and recommendations for dental diseases prevention and treatment were given for each region group. For students from Africa the leading direction is caries prevention. Students from Middle East and Latin America need in caries treatment and endodontic treatment. The main problem of students from Asia is periodontal diseases.

[Regulatory science: modern trends in science and education for pharmaceutical products].

This article reviews modern trends in development of new instruments, standards and approaches to drugs safety, efficacy and quality assessment in USA and EU that can be called by unique term--"regulatory science" which is a new concept for Russian Federation. New education programs (curricula) developed by USA and EU universities within last 3 years are reviewed. These programs were designed in order to build workforce capable to utilize science approach for drug regulation. The principal mechanisms for financing research in regulatory science used by Food and Drug Administration are analyzed. There are no such science and relevant researches in Russian Federation despite the high demand as well as needs for the system for higher education and life-long learning education of specialists for regulatory affairs (or compliance).